Assignment 2: Introduction and Revised PICOT QuestionRevise your PICOT question on the basis of the feedback you received on Week 3 Assignment 2. Submit your introduction and revised PICOT question as

EDITORIAL Medication-assisted treatment for opioid dependence in Twelve Step–oriented residential rehabilitation settings Marc Galanter, MD a, Marvin Seppala, MD b, and Audrey Klein, PhD b aDepartment of Psychiatry, New York University School of Medicine, New York, New York, USA; bHazelden/Betty Ford Foundation, Center City, Minnesota, USA Noncommunicable diseases are a major focus of attention of the World Health Organization, 1and drug misuse is among the 25 leading causes of risk for mortality worldwide. 2One recent example of this problem is evident in the United States, with a rise in the last 15 years in opioid addiction as a cause of death. 3The use of medication for treatment for opioid addic- tion, most recently in the form of buprenorphine and depot naltrexone, has led to a focus on the employment of medica- tion-assisted treatment along with psychosocial approaches for opioid-dependent patients. Attention to this approach was underlined by the recent announcement by the US president of a major initiative to expand access to medication-assisted treat- ment for opioid use disorders. 4One area where consideration of this approach can be addressed is the widespread use of free- standing residential rehabilitation programs for substance use treatment. In the United States, there are 3450 such programs oriented to addiction rehabilitation that are not hospital- affiliated.

Contemporary residential rehabilitation programs for alcohol and drug use disorders originated in the 1940s with the wedding of professional care to Twelve Step–based recovery. At that time, this approach was directed to dependence on alcohol, for which the fel- lowship of Alcoholics Anonymous(AA) had originally been devel- oped. It was only later that people addicted to other drugs came to be treated in Twelve Step–based facilities.

With the increase of addiction to narcotic analgesics and heroin in recent years, the issue can be raised as to whether medication-assisted treatment (MAT) can be adopted in the Twelve Step–oriented rehabilitation settings to best address the needs of opioid-dependent patients who may be admitted. This has raised concerns among some clinicians committed to AA- based recovery about the compatibility of the Twelve Step model with opioid maintenance on a dependency-producing agent such as buprenorphine, or on an opioid antagonist. This relates to a fundamental issue for them, of how the biomedi- cally oriented and the Twelve Step approaches can be combined to yield an outcome that can be superior to either approach alone. We write here to discuss the feasibility of implementing such a combined approach in established Twelve Step–based residential rehabilitation settings, in order to achieve improved clinical outcome for opioid addicts. Magnitude of the problem There have been 2 related trends in the United States in recent years regarding opioid use disorders. Thefirst relates to non- medical use of prescription narcotics, yielding a marked increase in the prevalence of high frequency use of these anal- gesics and related substance use disorders. 5This has generated public health efforts geared at cutting back on the excessive pre- scribing of opioid analgesic medications by means such as state-based prescription monitoring and the development of guidelines for proper treatment of pain in substance-abusing patients. 6 A second trend has been the transition of many people from dependence on opioid analgesics to heroin. 7Among people with substance use disorders surveyed, exclusive use of heroin more than doubled between 2008 and 2014, with nearly half of those sur- veyed reporting having moved on to heroin from nonmedical use of narcotic analgesics. 8Indeed, the portion of admissions for opioid dependence among substance abuse treatment admissions increased from 11% in 1992 to 19% in 2013. 2 Treating opioid dependence with MAT in the rehabilitation setting Inpatient rehabilitation unitsareamajorresourceformanaging substance-dependent people in the United States, and most make use of a Twelve Step–oriented approach; some see engagement in theTwelveStepformatasaprimarygoal following discharge. Prior to the current increase in opioid problems, the outcome of treat- ment in a systematically managed Twelve Step–oriented inpatient rehabilitation program had been reported to be positive. 9This approach has been useful for alcohol use disorders, for which medi- cationshavebeenfoundtobeofsomebenefit, 10and for cocaine- related disorders, for which there are no medications that have a material impact on clinical outcome. On the other hand, we do have medications that provide clear-cut benefit for opioid use dis- orders, and their use in the rehabilitation setting is understandably warranted.

Methadone, the most widely used medication for opioid dependence, can be prescribed in state-regulated clinics. Bupre- norphine, on the other hand, has been shown to be comparable CONTACTMarc Galanter, MD [email protected] Department of Psychiatry, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. © 2016 Taylor & Francis Group, LLC SUBSTANCE ABUSE 2016, VOL. 37, NO. 3, 381–383 http://dx.doi.org/10.1080/08897077.2016.1187241 in effectiveness to methadone as a maintenance medication 11 and can be prescribed by certified practitioners. Patient drop- out while on buprenorphine maintenance, however, particu- larly in early stages of treatment, does remain a problem. 12 Extended-release naltrexone, also employed for opioid depen- dence, administered intramuscularly, has been shown to pro- duce significantly longer treatment retention than placebo, 13 but long-term outcome studies on this modality after the early stages of treatment have yet to be conducted. Findings among members of Narcotics Anonymous suggest that Twelve Step membership can be beneficial in achieving abstinence among opioid-dependent people. One recent survey showed that those whose primary drug problem was that of heroin-dependent individuals constituted 28% of NA members, and those with a primary problem of“other opioids,”13%. 14 Combining Twelve Step and medication approaches for MAT, however, can raise certain problems. A particularly salient issue is the difference in orientation between clinical staff who deliver Twelve Step model, abstinence-based treat- ment, 15 many of whom are in that very mode of recovery.

Additionally, there is a relative lack of experience with Twelve Step approaches within the maintenance-oriented medical community. Despite this, there have been attempts to adapt the Twelve Step model for patients in methadone clinics. For exam- ple, Methadone Anonymous 16 has drawn on the Twelve Step model for rehabilitating methadone-maintained patients, but operates independent of either the AA or NA fellowship struc- tures. Given the large number of opioid-dependent people maintained on buprenorphine, some have begun to attend Twelve Step groups, and in such cases, a positive correlation between the level of group attendance and ongoing abstinence has been reported. 17 Medication-assisted treatment in inpatient rehabilitation There has been a marked increase in opioid-related admis- sions in recent years in Twelve Step–oriented residential rehabilitation settings. In one such setting, Hazelden–Betty Ford in Minnesota, the portion of admissions that were opi- ate-related between 2001 and 2011 had increased from 19% to 30% of adults, and from 15% to 41% of adolescents. Opi- oid-dependent patients, many of whom had transitioned from narcotic analgesics to heroin addiction, were found to experience considerable morbidity and mortality after dis- charge from inpatient care, as clinically observed in numer- ous settings, including Hazelden.

Combining MAT and Twelve Step facilitation The value of employing MAT in such residential settings, which employ a Twelve Step–oriented format, despite potential conflicts in treatment orientation, appears to be clinically indicated. Twelve Step facilitation (TSF), a manual-guided treatment for alcohol and substance use disorders, is a systematic way of integrating AA attendance into professional care. It has been shown to yield clinical results similar to those of motivational enhancement and cognitive behavioral therapy in the individual therapeutic setting. 18 Addi- tionally, Twelve Step approaches are employed in many, but notall, alcoholism treatment programs, and TSFfindings are relevant here. In one naturalistic study, a Twelve Step–oriented program was found to provide better outcomes than one oriented to cogni- tive-behavioral therapy (CBT). 19It is relevant to rehabilitation in that greater duration of patient retention in TSF-based treatment has been found to be associated with better outcomes. 20 Thesefindings suggest that promoting Twelve Step atten- dance over the course of an extended residential stay may enhance treatment outcomes because it continues to be rein- forced over the course of residence there. Such residential set- tings may therefore be suitable for introducing MAT into an extended Twelve Step–oriented stay. A strong therapeutic alli- ance between patient and staff members has been shown to enhance TSF outcome, 21and with proper training, staff in resi- dential settings could be oriented so as to maximize their alli- ance with patients to support combining a Twelve Step approach and MAT over the course of a residential stay. Fur- thermore, a group-based format for patients has been demon- strated to be clinically useful. 22 Its use in residential settings may also be adapted for MAT.

The potential benefit in terms of long-term substance use outcome for MAT in“rehab”settings remains to be deter- mined. The Hazelden–Betty Ford Center for Research, for example, is currently conducting a study of patients treated in this manner. The successful initiation of such a program, with appropriate orientation, depends on Twelve Step–oriented staff accepting the introduction of buprenorphine or depot naltrex- one for opioid-dependent patients and on patients being willing to engage with this type of treatment. Given this, the need for reducing postdischarge morbidity and mortality of opioid- dependent people from residential rehabilitation settings, it would be advisable to implement such programmatic options more widely. References [1] World Health Organization.Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. Geneva, Switzerland: World Health Organization; 2013.

[2] Lozano R, Naghavi M, Foreman K, et al. Global and regional mortal- ity from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Lancet. 2012;280:2095–2128.

[3] Maxwell JC. The pain reliever and heroin epidemic in the United States:

shifting winds in the perfect storm.J Addict Dis. 2015;34:127–140.

[4] Botticelli M. Addressing the epidemic of prescription opioid abuse and heroin use.https://www.whitehouse.gov/blog/2016/02/01/preventing- epidemic-opioid-abuse-and-heroin-use. Accessed March 1, 2014.

[5] Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013.JAMA. 2015;314:1468–1478.

[6] Cheatle M, Comer D, Wunsch M, Skoufalos A, Reddy Y. Treating pain in addicted patients: recommendations from an expert panel.

Popul Health Manag. 2014;17:79–89.

[7] Mars SG, Fessel JN, Bourgois P, Montero F, Karandinos G, Ciccarone D.

Heroin-related overdose: the unexplored influences of markets, market- ing and source-types in the United States.Soc Sci Med. 2015;140:44–53.

[8] Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opi- oid and heroin abuse in the United States.N Engl J Med.

2015;373:1789–1790.

[9] Stinchfield R, Owen P. Hazelden’s model of treatment and its out- come.Addict Behav. 1998;23:669–683. 382 M. GALANTER ET AL.

[10] Jonas DE, Amick HR, Feitner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systemic review and meta-analysis.JAMA. 2014;311:1889–1900.

[11] Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.Addiction. 2009;104:1193–1200.

[12] Weiss RD, Potter JS, Fiellin DA, et al. Adjunctive counseling during brief and extended buprenorphine-nalaxone treatment for prescrip- tion opioid dependence: a 2-phase randomized controlled trial.Arch Gen Psychiatry. 2011;68:1238–1246.

[13] Comer SD, Sullivan MA, Yu E, et al. Injectable, sustained-release nal- trexone for the treatment of opioid dependence: a randomized, pla- cebo-controlled trial.Arch Gen Psychiatry. 2006;63:210–218.

[14] Galanter M, Dermatis H, Post S, Santucci C. Abstinence from drugs of abuse in community-based members of Narcotics Anonymous.J Stud Alcohol Drugs. 2013;74:349–352.

[15] Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies: tackling the opioid-overdose epidemic.NEnglJMed.

2014;370:2063–2066.

[16] Gilman S, Galanter M, Dermatis H. Methadone Anonymous: a 12- step program for methadone maintained heroin addicts.Subst Abus.

2001;22:247–256.[17] Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O’Grady KE, Jaffe JH. Buprenorphine treatment and 12-step meeting atten- dance: conflicts, compatibilities, and patient outcomes.JSubst Abuse Treat. 2015;57:89–95.

[18] Project Match Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH post treatment drinking out- comes.J Stud Alcohol. 1997;58:7–29.

[19] Moos R, Moos B, Andrassy J. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders.Psychiatr Serv. 1999;50:1577– 1583.

[20] Timko C, DeBenedetti A, Billow R. Intensive referral to 12-Step self- help groups and 6-month substance use disorder outcomes.Addic- tion. 2006;101:678–688.

[21] Campbell BK, Guydish J, Le T, Wells EA, McCarty D. The relation- ship of therapeutic alliance and treatment deliveryfidelity with treat- ment retention in a multisite trial of Twelve-Step facilitation.Psychol Addict Behav. 2015;29:106–113.

[22] Kaskutas LA, Subbaraman MS, Witbrodt J, Zemore SE. Effec- tiveness of making Alcoholics Anonymous easier: a group for- mat 12-step facilitation approach.JSubstAbuseTreat.

2009;37:228–239. SUBSTANCE ABUSE 383 Copyright ofSubstance Abuseisthe property ofTaylor &Francis Ltdand itscontent maynot be copied oremailed tomultiple sitesorposted toalistserv without thecopyright holder's express writtenpermission. However,usersmayprint, download, oremail articles for individual use.